• Online Features  This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (69)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Some Therapeutic Considerations Relative to Long-Term Dialysis and Transplantation

Milton E. Rubini, MD; Jack W. Coburn, MD; Shaul G. Massry, MD; James H. Shinaberger, MD

Arch Intern Med. 1969;124(6):663-669.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

This communication will review some of the therapeutic considerations of renal osteodystrophy in light of the material presented in this symposium. From the clinical point of view, the problem of renal osteodystrophy is twofold. First is the definition and pathogenesis. The process of skeletal alteration probably starts quite early in the course of renal disease and progresses with further deterioration of renal function. It includes features of vitamin D resistance or lack which would seem susceptible to early therapy. There is, however, a second clinical presentation of renal osteodystrophy that occurs predominantly in patients with advanced and long-standing uremia, and especially in patients whose life is extended by dialysis. Most of our experience with renal osteodystrophy has been with this latter disease—a process which seemingly developed under our direct observation. This form of renal osteodystrophy may progress rapidly, particularly in patients treated with long-term dialysis and seems to be due . . . [Full Text PDF of this Article]

Author Affiliations

From the Department of Medicine, Veterans Administration Center (Drs. Rubini, Coburn, and Shinaberger), the Department of Medicine, Cedars-Sinai Medical Center (Dr. Massry), and the UCLA Center for the Health Sciences, Los Angeles. Dr. Massry is an established investigator for the American Heart Association.

Footnotes

Read before the Conference on Divalent Ion Metabolism and Osteodystrophy in Chronic Renal Failure, Santa Barbara, Calif, Nov 19, 1968.

Reprint requests to the Department of Medicine, Veterans Administration Center, Los Angeles (Dr. Rubini).

CiteULike    Connotea    Delicious    Digg    Facebook    Reddit    Technorati    Twitter     What's this?